Medical City Fort Worth has expanded access to CAR-T Therapy with the first post-infusion monitoring program in Tarrant County. The hospital will provide inpatient monitoring and management following outpatient CAR-T infusions, a critical phase that requires specialized expertise and rapid-response capabilities. The program allows patients to receive advanced cancer treatment closer to home while maintaining coordination with certified treatment centers. CAR-T therapy is a personalized treatment that modifies a patient’s immune cells to identify and attack cancer, and demand has grown as outcomes improve for certain conditions. “By extending access to CAR-T therapy, we are advancing our mission to bring innovative, life-saving treatments closer to where our patients live,” said Bibas Reddy, DO, oncology medical director. “Ensuring that hospital-based teams are fully equipped to monitor and manage patients during the post-infusion phase is critical to promoting safe recovery and achieving the best possible outcomes.”
Parkland Health has been selected for the National Workforce Well-Being Initiative as one of 26 organizations in the National Academy of Medicine Program. The Dallas-based health system will participate in the Change Maker Accelerators, a yearlong initiative that provides coaching, tools, and peer collaboration to help address clinician burnout and implement measurable support strategies. Participants will collaborate through national learning sessions and small peer groups, sharing insights and best practices with organizations across the country. “Supporting the people who care for our community is essential to delivering safe, high-quality care,” said Dr. Jennifer Wimberly, medical director of clinical ethics and resiliency. “This opportunity allows us to build on the work already underway and continue advancing meaningful, sustainable solutions for our teams.”
Plano-Based Percipio Health has joined the American Heart Association Innovators’ Network to advance AI-driven care solutions. The network connects providers, researchers, entrepreneurs, and payers to collaborate on scalable solutions in cardiovascular and brain health. Membership provides access to clinical guidelines, research frameworks, and opportunities to participate in outcome-based studies that support the adoption of new technologies. Percipio Health develops AI-powered population health tools that use smartphone-based assessments and analytics to identify patient risk earlier and streamline care planning. Participation in the network helps reduce the cost and complexity of clinical validation, a key barrier for digital health companies seeking broader use among providers and payers. “Percipio’s participation in the network will allow Percipio to collaborate with members on the intersection of science and technology that could leverage AI to potentially scale cardiovascular care to large populations, in a device-free manner,” said Eric Rock, CEO and co-founder of Percipio Health…